Electromed (NYSE:ELMD) Stock Rating Lowered by StockNews.com

Electromed (NYSE:ELMD) was downgraded by stock analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued on Thursday.

Separately, TheStreet raised Electromed from a “c+” rating to a “b-” rating in a report on Wednesday, February 21st.

Electromed Price Performance

Shares of NYSE ELMD opened at $14.18 on Thursday. The company has a market capitalization of $122.09 million, a price-to-earnings ratio of 31.51 and a beta of 0.43. The business has a 50-day moving average of $15.18 and a two-hundred day moving average of $12.09. Electromed has a 1 year low of $8.80 and a 1 year high of $17.85.

Electromed (NYSE:ELMD) last announced its quarterly earnings results on Tuesday, February 13th. The company reported $0.19 earnings per share (EPS) for the quarter. The company had revenue of $13.69 million during the quarter. Electromed had a return on equity of 10.32% and a net margin of 7.62%.

Institutional Trading of Electromed

Hedge funds and other institutional investors have recently made changes to their positions in the company. Cetera Advisor Networks LLC acquired a new stake in shares of Electromed during the second quarter worth about $129,000. State Street Corp increased its position in shares of Electromed by 23.3% during the first quarter. State Street Corp now owns 14,529 shares of the company’s stock worth $181,000 after purchasing an additional 2,742 shares in the last quarter. Gabelli Funds LLC increased its position in shares of Electromed by 17.3% during the fourth quarter. Gabelli Funds LLC now owns 20,367 shares of the company’s stock worth $222,000 after purchasing an additional 3,000 shares in the last quarter. BlackRock Inc. increased its position in shares of Electromed by 7.6% during the second quarter. BlackRock Inc. now owns 20,521 shares of the company’s stock worth $220,000 after purchasing an additional 1,452 shares in the last quarter. Finally, Northern Trust Corp increased its position in shares of Electromed by 4.7% during the second quarter. Northern Trust Corp now owns 29,078 shares of the company’s stock worth $311,000 after purchasing an additional 1,306 shares in the last quarter. Institutional investors and hedge funds own 40.82% of the company’s stock.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.